Oleg Pavlish
- Oncology top 10%
- Viral-associated cancers and disorders 8
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 7
-
- T-cell and Retrovirus Studies 4
-
- Eosinophilic Disorders and Syndromes 4
-
- Animal Disease Management and Epidemiology 3
-
- Histiocytic Disorders and Treatments 2
-
- Viral Infections and Immunology Research 1
-
- NF-κB Signaling Pathways 1
- Co-authors
- Gilbert LenoirG. W. BornkammMarc BillaudThomas TurszGermain RousseletAlain CalenderJacques BanchereauM. Cordier
- Journals
- International Journal of Cancer (3 papers)Journal of Virology (3 papers)Journal of Biological Chemistry (1 paper)
- Partner nations
- RussiaUnited KingdomJapan
In The Last Decade
Oleg Pavlish
12 papers receiving 339 citations
Peers
Comparison fields: 5 of 37
- Oncology 264
- Pathology and Forensic Medicine 155
- Immunology 106
- Infectious Diseases 73
- Rheumatology 52
Countries citing papers authored by Oleg Pavlish
This map shows the geographic impact of Oleg Pavlish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oleg Pavlish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oleg Pavlish more than expected).
Fields of papers citing papers by Oleg Pavlish
This network shows the impact of papers produced by Oleg Pavlish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oleg Pavlish. The network helps show where Oleg Pavlish may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Oleg Pavlish, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 7 | |
| 2 | 2015 | 2 | |
| 3 | 2008 | 10 | |
| 4 | 2003 | 36 | |
| 5 | 2001 | 36 | |
| 6 | 1998 | 13 | |
| 7 | 1998 | 3 | |
| 8 | [Distribution and phylogenetic analysis of HTLV-I isolates, persisting in the Russian Far East]. | 1996 | 6 |
| 9 | 1993 | 6 | |
| 10 | 1990 | 153 | |
| 11 | 1990 | 37 | |
| 12 | 1989 | 39 |
About Oleg Pavlish
Oleg Pavlish is a scholar working on Pathology and Forensic Medicine, Agronomy and Crop Science and Oncology, having authored 12 papers that have together received 348 indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (7 papers), T-cell and Retrovirus Studies (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Animal Disease Management and Epidemiology (3 papers), Histiocytic Disorders and Treatments (2 papers), Viral Infections and Immunology Research (1 paper) and NF-κB Signaling Pathways (1 paper). The work is most often cited by research in Oncology (264 citations), Pathology and Forensic Medicine (155 citations) and Immunology (106 citations). Oleg Pavlish has collaborated with scholars based in Russia, United Kingdom and Japan. Frequent co-authors include Gilbert Lenoir, G. W. Bornkamm, Marc Billaud, Thomas Tursz, Germain Rousselet, Alain Calender, Jacques Banchereau, M. Cordier, Vladimir Gurtsevitch and Andrey A. Parkhitko. Their work appears in journals such as International Journal of Cancer, Journal of Virology, Journal of Biological Chemistry, Leukemia Research and Biochemistry (Moscow).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.